SlideShare una empresa de Scribd logo
1 de 22
3D QSAR
PROTOCOL AND APPLICATIONS
Mahendra.G.S.
M.Pharm 1st year
Pharmaceutical Chemistry
JSS College of Pharmacy,
Mysore
CONTENTS:
 Introduction to QSAR
 3D QSAR
 COMFA
 COMSIA
 Applications
 Case study
INTRODUCTION TO QSAR
• To relate the biological activity of a series of compounds to their
physicochemical parameters in a quantitative fashion using a mathematical
formula.
• The fundamental principe involved is difference in structural properties is
responsible for variations in biological activities of the compound.
• Physico-chemical parameters:
Hydrophobicity of substituents
Electronic properties of substituents
Hydrophobicity of the molecule
Steric properties of substituents
• Hansch Analysis:
Corelates biological activity with physico-chemical parsmeters.
Log(1/c) = k1 logP + k2 σ + k3 Es + k4
• Free-Wilson Analysis:
Corelates biological activity with certain structural features of the compound.
Limitation:
Does not consider 3D structure.
No graphical output thereby making the interpretation of results in familiar
chemical terms, frequently difficult if not impossible
3D QSAR
• 3D QSAR is an extension of classical QSAR which exploits the 3 dimensional
properties of the ligands to predict their biological activity using robust stastical
analysis like PLS, G/PLS, ANN etc.
• 3D-QSAR uses probe-based sampling within a molecular lattice to determine
three-dimensional properties of molecules and can then correlate these 3D
descriptors with biological activity.
• No QSAR model can replace the experimental assays, though experimental
techniques are also not free from errors.
• Some of the major factors like desolvation energetics, temperature, diffusion,
transport, pH, salt concentration etc. which contribute to the overall free energy
of binding are difficult to handle, and thus usually ignored.
• Regardless of all such problems, QSAR becomes a useful alternative approach.
3d qsar
CoMFA(Comparative Molecular Field Analysis)
• In 1987, Cramer developed the predecessor of 3D approaches called Dynamic
Lattice-Oriented Molecular Modeling System (DYLOMMS) that involves the use
of PCA to extract vectors from the molecular interaction fields, which are then
correlated with biological activities.
• Soon after he modified it by combining the two existing techniques, GRID and
PLS, to develop a powerful 3D QSAR methodology, Comparative Molecular
Field Analysis (CoMFA).
• The underlying idea of CoMFA is that differences in a target property, e.g.,
biological activity, are often closely related to equivalent changes in shapes and
strengths of non-covalent interaction fields surrounding the molecules.
• Hence, the molecules are placed in a cubic grid and the interaction energies
between the molecule and a defined probe are calculated for each grid point.
Protocol for CoMFA:
A standard CoMFA procedure, as implemented in the Sybyl Software,
follows the following sequential steps:
• Bioactive conformations of each molecule are determined.
• All the molecules are superimposed or aligned using either manual or automated
methods, in a manner defined by the supposed mode of interaction with the
receptor.
• The overlaid molecules are placed in the center of a lattice grid with a spacing of
2 Å.
• The algorithm compares, in three-dimensions, the steric and electrostatic fields
calculated around the molecules with different probe groups positioned at all
intersections of the lattice.
• The interaction energy or field values are correlated with the biological activity
data using PLS technique, which identifies and extracts the quantitative influence
of specific chemical features of molecules on their biological activity.
• The results are articulated as correlation equations with the number of latent
variable terms, each of which is a linear combination of original independent
lattice descriptors.
• For visual understanding, the PLS output is presented in the form of an
interactive graphics consisting of colored contour plots of coefficients of the
corresponding field variables at each lattice intersection, and showing the
imperative favorable and unfavorable regions in three dimensional space which
are considerably associated with the biological activity.
DRAWBACKS AND LIMITATIONS OF CoMFA
CoMFA has several pitfalls and imperfections:
• Too many adjustable parameters like overall orientation, lattice placement, step
size, probe atom type etc.
• Uncertainty in selection of compounds and variables
• Fragmented contour maps with variable selection procedures
• Hydrophobicity not well-quantified
• Cut-off limits used
• Low signal to noise ratio due to many useless field variables
• Imperfections in potential energy functions
• Various practical problems with PLS
• Applicable only to in vitro data
CoMSIA
• Comparative Molecular Similarity Indices Analysis (CoMSIA) was developed to
overcome certain limitations of CoMFA.
• In CoMSIA, molecular similarity indices calculated from modified SEAL
similarity fields are employed as descriptors to simultaneously consider steric,
electrostatic, hydrophobic and hydrogen bonding properties.
• These indices are estimated indirectly by comparing the similarity of each
molecule in the dataset with a common probe atom (having a radius of 1 Å,
charge of +1 and hydrophobicity of +1) positioned at the intersections of a
surrounding grid/lattice.
• For computing similarity at all grid points, the mutual distances between the
probe atom and the atoms of the molecules in the aligned dataset are also taken
into account.
• To describe this distance-dependence and calculate the molecular properties,
Gaussian-type functions are employed. Since the underlying Gaussian-type
functional forms are ‘smooth’ with no singularities, their slopes are not as steep as
the Coulombic and Lennard-Jones potentials in CoMFA; therefore, no arbitrary cut-
off limits are required to be defined.
• CoMSIA is provided by Tripos Inc. in the Sybyl software [33], along with CoMFA.
APPLICATIONS:
1. QSAR in Chromatography: Quantitative Structure–Retention Relationships
(QSRRs)
2. The Use of QSAR and Computational Methods in Drug Design.
3. In Silico Approaches for Predicting ADME Properties.
4. Prediction of Harmful Human Health Effects of Chemicals from Structure.
5. Chemometric Methods and Theoretical Molecular Descriptors in Predictive
QSAR Modeling of the Environmental Behavior of Organic Pollutants
6. The Role of QSAR Methodology in the Regulatory Assessment of Chemicals
7. Nanomaterials – the Great Challenge for QSAR Modelers
Case study:Human Eosinophil Phosphodiesterase
• The phosphodiesterase type IV (PDE4) plays an important role in regulating
intracellular levels of cAMP and cGMP.
• PDE4 has highly expressed in inflammatory and immune cells and airway smooth
muscle and degrade the cAMP’s concentration.
• The inhibition of PDE4 increase the intracellular cAMP concentrations to kill
inflammatory cells and relax airway smooth muscle.
• To develop the selective PDE4 inhibitors as anti-inflammatory and asthmatic
drugs has attracted extensive research has been conducted. The QSAR studies of
PDE4 inhibitors have also been done by using CoMFA and CoMSIA methods.
• More potent and selective PDE4 inhibitors, a series of 5,6-dihydro-(9H) -
pyrazolo[3,4-c] -1,2,4-triazolo [4,3R]pyridine, were improved and synthesized
based on the structures of 7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] pyridine.
• In order to study the interaction mechanism of PDE4 with 31 new compounds,
the QSAR model was built by using the CoMFA.
5,6-dihydro-(9H) -pyrazolo[3,4-
c] -1,2,4-triazolo [4,3R]pyridine
Four compounds were randomly selected as test set, other twenty-seven compounds as
training set.
Method:
The structures of 31 compounds were built with molecular sketch program. Then
Gasteiger-Hückel charges were assigned to each atom and the energy minimization
of each molecule.
All the compounds studied had common rigid substructure. Therefore, the common
rigid substructure alignment was carried out by using database alignment tool. The
most active compound cyclobutyl substituent is used as template molecule.
• All aligned molecules were put into a 3D cubic lattice that extending at least 4 Å beyond
the volumes of all investigated molecules on all axes. In the 3D lattice, the grid spacing
was set to 2.0 Å in the x, y, and z directions.
• A sp3hybrized carbon atom with a charge of +1 was used as the probe atom, CoMFA
steric and electrostatic interaction fields were calculated.
• Partial least squares method was carried out to build the 3D-QSAR models. Leave-one-
out (LOO) cross-validated PLS analysis was used to check the predictive ability of the
models and to determine the optimal number of components to be used in the final
QSAR models.
• The PLS analysis gave a CoMFA model with cross-validated q2 value of 0.565 for 3
optimal components. The non-cross-validated PLS analysis of these compounds was
repeated with the optimal number of components and the R2 value was 0.867.
3d qsar
CONCLUSION
CoMFA and CoMSIA are useful techniques in understanding pharmacological
properties of studied compounds, and they have been successfully used in modern
drug design. Despite of all the pitfalls it has now been globally used for drug
discovery based on well-established principles of statistics, is intrinsically a valuable
and viable medicinal chemistry tool whose application domain range from explaining
the structure-activity relationships quantitatively and retrospectively, to endowing
synthetic guidance leading to logical and experimentally testable hypotheses. Apart
from synthetic applications it has also been used in various other fields too.
Reference
1. An Introduction to Medicinal Chemistry FIFTH EDITION by Graham L. Patrick
2. Yuhong Xiang, Zhuoyong Zhang*, Aijing Xiao, and Jinxu Huo “Recent Studies of
QSAR on Inhibitors of Estrogen Receptor and Human Eosinophil
Phosphodiesterase” Department of Chemistry, Capital Normal University, Beijing
100048, P.R. China
3. Jitender Verma, Vijay M. Khedkar and Evans C. Coutinho “3D-QSAR in Drug
Design - A Review” Department of Pharmaceutical Chemistry, Bombay College of
Pharmacy, Kalina, Santacruz (E), Mumbai 400 098, India
3d qsar

Más contenido relacionado

La actualidad más candente

QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)Satigayatri
 
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDQSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDGagangowda58
 
Hansch and Free-Wilson QSAR Models
Hansch and Free-Wilson QSAR ModelsHansch and Free-Wilson QSAR Models
Hansch and Free-Wilson QSAR ModelsAkshay Kank
 
Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Theabhi.in
 
Drug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant YadavDrug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant YadavKashikant Yadav
 
molecular docking its types and de novo drug design and application and softw...
molecular docking its types and de novo drug design and application and softw...molecular docking its types and de novo drug design and application and softw...
molecular docking its types and de novo drug design and application and softw...GAUTAM KHUNE
 
Relationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysisRelationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysisKomalJAIN122
 
STATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARSTATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARRaniBhagat1
 
In Silico methods for ADMET prediction of new molecules
 In Silico methods for ADMET prediction of new molecules In Silico methods for ADMET prediction of new molecules
In Silico methods for ADMET prediction of new moleculesMadhuraDatar
 
Free wilson analysis
Free wilson analysisFree wilson analysis
Free wilson analysisASHOK GAUTAM
 
Quantitative structure activity relationships
Quantitative structure  activity relationshipsQuantitative structure  activity relationships
Quantitative structure activity relationshipsAmiya ghosh
 
De novo drug design
De novo drug designDe novo drug design
De novo drug designmojdeh y
 
Rational drug design method
Rational drug design methodRational drug design method
Rational drug design methodRangnathChikane
 

La actualidad más candente (20)

SAR & QSAR
SAR & QSARSAR & QSAR
SAR & QSAR
 
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
 
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDQSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
 
Virtual sreening
Virtual sreeningVirtual sreening
Virtual sreening
 
Hansch and Free-Wilson QSAR Models
Hansch and Free-Wilson QSAR ModelsHansch and Free-Wilson QSAR Models
Hansch and Free-Wilson QSAR Models
 
Rationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration ofRationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration of
 
Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)
 
Drug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant YadavDrug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant Yadav
 
molecular docking its types and de novo drug design and application and softw...
molecular docking its types and de novo drug design and application and softw...molecular docking its types and de novo drug design and application and softw...
molecular docking its types and de novo drug design and application and softw...
 
Relationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysisRelationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysis
 
STATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARSTATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSAR
 
De Novo Drug Design
De Novo Drug DesignDe Novo Drug Design
De Novo Drug Design
 
Qsar
QsarQsar
Qsar
 
Denovo Drug Design
Denovo Drug DesignDenovo Drug Design
Denovo Drug Design
 
In Silico methods for ADMET prediction of new molecules
 In Silico methods for ADMET prediction of new molecules In Silico methods for ADMET prediction of new molecules
In Silico methods for ADMET prediction of new molecules
 
Free wilson analysis
Free wilson analysisFree wilson analysis
Free wilson analysis
 
Quantitative structure activity relationships
Quantitative structure  activity relationshipsQuantitative structure  activity relationships
Quantitative structure activity relationships
 
Lead identification
Lead identification Lead identification
Lead identification
 
De novo drug design
De novo drug designDe novo drug design
De novo drug design
 
Rational drug design method
Rational drug design methodRational drug design method
Rational drug design method
 

Similar a 3d qsar

Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipRaniBhagat1
 
Lecture 5 pharmacophore and qsar
Lecture 5  pharmacophore and  qsarLecture 5  pharmacophore and  qsar
Lecture 5 pharmacophore and qsarRAJAN ROLTA
 
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Atai Rabby
 
DRUG TARGETS AND DRUG DESIGNING.pptx
DRUG TARGETS AND DRUG DESIGNING.pptxDRUG TARGETS AND DRUG DESIGNING.pptx
DRUG TARGETS AND DRUG DESIGNING.pptxHumaRao8
 
QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship ZarlishAttique1
 
Macromolecular interaction
Macromolecular interactionMacromolecular interaction
Macromolecular interactionCharthaGaglani
 
cadd-191129134050 (1).pptx
cadd-191129134050 (1).pptxcadd-191129134050 (1).pptx
cadd-191129134050 (1).pptxNoorelhuda2
 
2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA values2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA valuesvarun Kundi
 
Superimposition method- ligand based drug design
Superimposition method- ligand based drug designSuperimposition method- ligand based drug design
Superimposition method- ligand based drug designIshpreet Sachdev
 

Similar a 3d qsar (20)

3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis
 
Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity Relationship
 
Lecture 5 pharmacophore and qsar
Lecture 5  pharmacophore and  qsarLecture 5  pharmacophore and  qsar
Lecture 5 pharmacophore and qsar
 
3D-QSAR.pptx
3D-QSAR.pptx3D-QSAR.pptx
3D-QSAR.pptx
 
QSPR For Pharmacokinetics
QSPR For PharmacokineticsQSPR For Pharmacokinetics
QSPR For Pharmacokinetics
 
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)
 
Qsar
QsarQsar
Qsar
 
DRUG TARGETS AND DRUG DESIGNING.pptx
DRUG TARGETS AND DRUG DESIGNING.pptxDRUG TARGETS AND DRUG DESIGNING.pptx
DRUG TARGETS AND DRUG DESIGNING.pptx
 
QSAR.pptx
QSAR.pptxQSAR.pptx
QSAR.pptx
 
QSAR by Faizan Deshmukh
QSAR by Faizan DeshmukhQSAR by Faizan Deshmukh
QSAR by Faizan Deshmukh
 
Drug design
Drug designDrug design
Drug design
 
3D QSAR.pptx
3D QSAR.pptx3D QSAR.pptx
3D QSAR.pptx
 
Scoring function
Scoring functionScoring function
Scoring function
 
QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship
 
Macromolecular interaction
Macromolecular interactionMacromolecular interaction
Macromolecular interaction
 
cadd-191129134050 (1).pptx
cadd-191129134050 (1).pptxcadd-191129134050 (1).pptx
cadd-191129134050 (1).pptx
 
docking
docking docking
docking
 
2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA values2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA values
 
JAI
JAIJAI
JAI
 
Superimposition method- ligand based drug design
Superimposition method- ligand based drug designSuperimposition method- ligand based drug design
Superimposition method- ligand based drug design
 

Más de Mahendra G S

Antibiotics-1.pptx
Antibiotics-1.pptxAntibiotics-1.pptx
Antibiotics-1.pptxMahendra G S
 
Tetracyclines.pptx
Tetracyclines.pptxTetracyclines.pptx
Tetracyclines.pptxMahendra G S
 
β-lactamase inhibitors.pptx
β-lactamase inhibitors.pptxβ-lactamase inhibitors.pptx
β-lactamase inhibitors.pptxMahendra G S
 
CEPHALOSPORIN.pptx
CEPHALOSPORIN.pptxCEPHALOSPORIN.pptx
CEPHALOSPORIN.pptxMahendra G S
 
Columnchromatography
ColumnchromatographyColumnchromatography
ColumnchromatographyMahendra G S
 
Quality assurance pharmaceutical analysis
Quality assurance  pharmaceutical analysisQuality assurance  pharmaceutical analysis
Quality assurance pharmaceutical analysisMahendra G S
 
Principle of UV visible Spectroscopy
Principle of UV visible SpectroscopyPrinciple of UV visible Spectroscopy
Principle of UV visible SpectroscopyMahendra G S
 
Thermogravimetric analysis(TGA)
Thermogravimetric analysis(TGA)Thermogravimetric analysis(TGA)
Thermogravimetric analysis(TGA)Mahendra G S
 
Radio immuno assay
Radio immuno assayRadio immuno assay
Radio immuno assayMahendra G S
 
Pericyclic reactions
Pericyclic reactions Pericyclic reactions
Pericyclic reactions Mahendra G S
 
Optical Rotatory Dispersion
Optical Rotatory DispersionOptical Rotatory Dispersion
Optical Rotatory DispersionMahendra G S
 
NMR Interpretation
NMR InterpretationNMR Interpretation
NMR InterpretationMahendra G S
 
Molecular maodeling and drug design
Molecular maodeling and drug designMolecular maodeling and drug design
Molecular maodeling and drug designMahendra G S
 

Más de Mahendra G S (20)

Antibiotics-1.pptx
Antibiotics-1.pptxAntibiotics-1.pptx
Antibiotics-1.pptx
 
Tetracyclines.pptx
Tetracyclines.pptxTetracyclines.pptx
Tetracyclines.pptx
 
β-lactamase inhibitors.pptx
β-lactamase inhibitors.pptxβ-lactamase inhibitors.pptx
β-lactamase inhibitors.pptx
 
CEPHALOSPORIN.pptx
CEPHALOSPORIN.pptxCEPHALOSPORIN.pptx
CEPHALOSPORIN.pptx
 
PENECILLINS.pptx
PENECILLINS.pptxPENECILLINS.pptx
PENECILLINS.pptx
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptx
 
Columnchromatography
ColumnchromatographyColumnchromatography
Columnchromatography
 
Quality assurance pharmaceutical analysis
Quality assurance  pharmaceutical analysisQuality assurance  pharmaceutical analysis
Quality assurance pharmaceutical analysis
 
Principle of UV visible Spectroscopy
Principle of UV visible SpectroscopyPrinciple of UV visible Spectroscopy
Principle of UV visible Spectroscopy
 
Thermogravimetric analysis(TGA)
Thermogravimetric analysis(TGA)Thermogravimetric analysis(TGA)
Thermogravimetric analysis(TGA)
 
Super critical FC
Super critical FCSuper critical FC
Super critical FC
 
Size exclusion
Size exclusionSize exclusion
Size exclusion
 
Ria elisa
Ria elisaRia elisa
Ria elisa
 
Radio immuno assay
Radio immuno assayRadio immuno assay
Radio immuno assay
 
QSAR
QSARQSAR
QSAR
 
Protecting Groups
Protecting GroupsProtecting Groups
Protecting Groups
 
Pericyclic reactions
Pericyclic reactions Pericyclic reactions
Pericyclic reactions
 
Optical Rotatory Dispersion
Optical Rotatory DispersionOptical Rotatory Dispersion
Optical Rotatory Dispersion
 
NMR Interpretation
NMR InterpretationNMR Interpretation
NMR Interpretation
 
Molecular maodeling and drug design
Molecular maodeling and drug designMolecular maodeling and drug design
Molecular maodeling and drug design
 

Último

How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
Riddhi Kevadiya. WILLIAM SHAKESPEARE....
Riddhi Kevadiya. WILLIAM SHAKESPEARE....Riddhi Kevadiya. WILLIAM SHAKESPEARE....
Riddhi Kevadiya. WILLIAM SHAKESPEARE....Riddhi Kevadiya
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 
EBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting BlEBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting BlDr. Bruce A. Johnson
 
Optical Fibre and It's Applications.pptx
Optical Fibre and It's Applications.pptxOptical Fibre and It's Applications.pptx
Optical Fibre and It's Applications.pptxPurva Nikam
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfMohonDas
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapitolTechU
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17Celine George
 
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...Dr. Asif Anas
 
A gentle introduction to Artificial Intelligence
A gentle introduction to Artificial IntelligenceA gentle introduction to Artificial Intelligence
A gentle introduction to Artificial IntelligenceApostolos Syropoulos
 
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxSlides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxCapitolTechU
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...M56BOOKSTORE PRODUCT/SERVICE
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsEugene Lysak
 

Último (20)

How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
Prelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quizPrelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quiz
 
Riddhi Kevadiya. WILLIAM SHAKESPEARE....
Riddhi Kevadiya. WILLIAM SHAKESPEARE....Riddhi Kevadiya. WILLIAM SHAKESPEARE....
Riddhi Kevadiya. WILLIAM SHAKESPEARE....
 
Finals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quizFinals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quiz
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 
EBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting BlEBUS5423 Data Analytics and Reporting Bl
EBUS5423 Data Analytics and Reporting Bl
 
Optical Fibre and It's Applications.pptx
Optical Fibre and It's Applications.pptxOptical Fibre and It's Applications.pptx
Optical Fibre and It's Applications.pptx
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdf
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptx
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17
 
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
 
A gentle introduction to Artificial Intelligence
A gentle introduction to Artificial IntelligenceA gentle introduction to Artificial Intelligence
A gentle introduction to Artificial Intelligence
 
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxSlides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...KARNAADA.pptx  made by -  saransh dwivedi ( SD ) -  SHALAKYA TANTRA - ENT - 4...
KARNAADA.pptx made by - saransh dwivedi ( SD ) - SHALAKYA TANTRA - ENT - 4...
 
March 2024 Directors Meeting, Division of Student Affairs and Academic Support
March 2024 Directors Meeting, Division of Student Affairs and Academic SupportMarch 2024 Directors Meeting, Division of Student Affairs and Academic Support
March 2024 Directors Meeting, Division of Student Affairs and Academic Support
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George Wells
 

3d qsar

  • 1. 3D QSAR PROTOCOL AND APPLICATIONS Mahendra.G.S. M.Pharm 1st year Pharmaceutical Chemistry JSS College of Pharmacy, Mysore
  • 2. CONTENTS:  Introduction to QSAR  3D QSAR  COMFA  COMSIA  Applications  Case study
  • 3. INTRODUCTION TO QSAR • To relate the biological activity of a series of compounds to their physicochemical parameters in a quantitative fashion using a mathematical formula. • The fundamental principe involved is difference in structural properties is responsible for variations in biological activities of the compound. • Physico-chemical parameters: Hydrophobicity of substituents Electronic properties of substituents Hydrophobicity of the molecule Steric properties of substituents
  • 4. • Hansch Analysis: Corelates biological activity with physico-chemical parsmeters. Log(1/c) = k1 logP + k2 σ + k3 Es + k4 • Free-Wilson Analysis: Corelates biological activity with certain structural features of the compound. Limitation: Does not consider 3D structure. No graphical output thereby making the interpretation of results in familiar chemical terms, frequently difficult if not impossible
  • 5. 3D QSAR • 3D QSAR is an extension of classical QSAR which exploits the 3 dimensional properties of the ligands to predict their biological activity using robust stastical analysis like PLS, G/PLS, ANN etc. • 3D-QSAR uses probe-based sampling within a molecular lattice to determine three-dimensional properties of molecules and can then correlate these 3D descriptors with biological activity. • No QSAR model can replace the experimental assays, though experimental techniques are also not free from errors. • Some of the major factors like desolvation energetics, temperature, diffusion, transport, pH, salt concentration etc. which contribute to the overall free energy of binding are difficult to handle, and thus usually ignored. • Regardless of all such problems, QSAR becomes a useful alternative approach.
  • 7. CoMFA(Comparative Molecular Field Analysis) • In 1987, Cramer developed the predecessor of 3D approaches called Dynamic Lattice-Oriented Molecular Modeling System (DYLOMMS) that involves the use of PCA to extract vectors from the molecular interaction fields, which are then correlated with biological activities. • Soon after he modified it by combining the two existing techniques, GRID and PLS, to develop a powerful 3D QSAR methodology, Comparative Molecular Field Analysis (CoMFA). • The underlying idea of CoMFA is that differences in a target property, e.g., biological activity, are often closely related to equivalent changes in shapes and strengths of non-covalent interaction fields surrounding the molecules. • Hence, the molecules are placed in a cubic grid and the interaction energies between the molecule and a defined probe are calculated for each grid point.
  • 8. Protocol for CoMFA: A standard CoMFA procedure, as implemented in the Sybyl Software, follows the following sequential steps: • Bioactive conformations of each molecule are determined. • All the molecules are superimposed or aligned using either manual or automated methods, in a manner defined by the supposed mode of interaction with the receptor. • The overlaid molecules are placed in the center of a lattice grid with a spacing of 2 Å. • The algorithm compares, in three-dimensions, the steric and electrostatic fields calculated around the molecules with different probe groups positioned at all intersections of the lattice.
  • 9. • The interaction energy or field values are correlated with the biological activity data using PLS technique, which identifies and extracts the quantitative influence of specific chemical features of molecules on their biological activity. • The results are articulated as correlation equations with the number of latent variable terms, each of which is a linear combination of original independent lattice descriptors. • For visual understanding, the PLS output is presented in the form of an interactive graphics consisting of colored contour plots of coefficients of the corresponding field variables at each lattice intersection, and showing the imperative favorable and unfavorable regions in three dimensional space which are considerably associated with the biological activity.
  • 10. DRAWBACKS AND LIMITATIONS OF CoMFA CoMFA has several pitfalls and imperfections: • Too many adjustable parameters like overall orientation, lattice placement, step size, probe atom type etc. • Uncertainty in selection of compounds and variables • Fragmented contour maps with variable selection procedures • Hydrophobicity not well-quantified • Cut-off limits used • Low signal to noise ratio due to many useless field variables • Imperfections in potential energy functions • Various practical problems with PLS • Applicable only to in vitro data
  • 11. CoMSIA • Comparative Molecular Similarity Indices Analysis (CoMSIA) was developed to overcome certain limitations of CoMFA. • In CoMSIA, molecular similarity indices calculated from modified SEAL similarity fields are employed as descriptors to simultaneously consider steric, electrostatic, hydrophobic and hydrogen bonding properties. • These indices are estimated indirectly by comparing the similarity of each molecule in the dataset with a common probe atom (having a radius of 1 Å, charge of +1 and hydrophobicity of +1) positioned at the intersections of a surrounding grid/lattice. • For computing similarity at all grid points, the mutual distances between the probe atom and the atoms of the molecules in the aligned dataset are also taken into account.
  • 12. • To describe this distance-dependence and calculate the molecular properties, Gaussian-type functions are employed. Since the underlying Gaussian-type functional forms are ‘smooth’ with no singularities, their slopes are not as steep as the Coulombic and Lennard-Jones potentials in CoMFA; therefore, no arbitrary cut- off limits are required to be defined. • CoMSIA is provided by Tripos Inc. in the Sybyl software [33], along with CoMFA.
  • 13. APPLICATIONS: 1. QSAR in Chromatography: Quantitative Structure–Retention Relationships (QSRRs) 2. The Use of QSAR and Computational Methods in Drug Design. 3. In Silico Approaches for Predicting ADME Properties. 4. Prediction of Harmful Human Health Effects of Chemicals from Structure. 5. Chemometric Methods and Theoretical Molecular Descriptors in Predictive QSAR Modeling of the Environmental Behavior of Organic Pollutants 6. The Role of QSAR Methodology in the Regulatory Assessment of Chemicals 7. Nanomaterials – the Great Challenge for QSAR Modelers
  • 14. Case study:Human Eosinophil Phosphodiesterase • The phosphodiesterase type IV (PDE4) plays an important role in regulating intracellular levels of cAMP and cGMP. • PDE4 has highly expressed in inflammatory and immune cells and airway smooth muscle and degrade the cAMP’s concentration. • The inhibition of PDE4 increase the intracellular cAMP concentrations to kill inflammatory cells and relax airway smooth muscle. • To develop the selective PDE4 inhibitors as anti-inflammatory and asthmatic drugs has attracted extensive research has been conducted. The QSAR studies of PDE4 inhibitors have also been done by using CoMFA and CoMSIA methods.
  • 15. • More potent and selective PDE4 inhibitors, a series of 5,6-dihydro-(9H) - pyrazolo[3,4-c] -1,2,4-triazolo [4,3R]pyridine, were improved and synthesized based on the structures of 7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] pyridine. • In order to study the interaction mechanism of PDE4 with 31 new compounds, the QSAR model was built by using the CoMFA. 5,6-dihydro-(9H) -pyrazolo[3,4- c] -1,2,4-triazolo [4,3R]pyridine
  • 16. Four compounds were randomly selected as test set, other twenty-seven compounds as training set.
  • 17. Method: The structures of 31 compounds were built with molecular sketch program. Then Gasteiger-Hückel charges were assigned to each atom and the energy minimization of each molecule. All the compounds studied had common rigid substructure. Therefore, the common rigid substructure alignment was carried out by using database alignment tool. The most active compound cyclobutyl substituent is used as template molecule.
  • 18. • All aligned molecules were put into a 3D cubic lattice that extending at least 4 Å beyond the volumes of all investigated molecules on all axes. In the 3D lattice, the grid spacing was set to 2.0 Å in the x, y, and z directions. • A sp3hybrized carbon atom with a charge of +1 was used as the probe atom, CoMFA steric and electrostatic interaction fields were calculated. • Partial least squares method was carried out to build the 3D-QSAR models. Leave-one- out (LOO) cross-validated PLS analysis was used to check the predictive ability of the models and to determine the optimal number of components to be used in the final QSAR models. • The PLS analysis gave a CoMFA model with cross-validated q2 value of 0.565 for 3 optimal components. The non-cross-validated PLS analysis of these compounds was repeated with the optimal number of components and the R2 value was 0.867.
  • 20. CONCLUSION CoMFA and CoMSIA are useful techniques in understanding pharmacological properties of studied compounds, and they have been successfully used in modern drug design. Despite of all the pitfalls it has now been globally used for drug discovery based on well-established principles of statistics, is intrinsically a valuable and viable medicinal chemistry tool whose application domain range from explaining the structure-activity relationships quantitatively and retrospectively, to endowing synthetic guidance leading to logical and experimentally testable hypotheses. Apart from synthetic applications it has also been used in various other fields too.
  • 21. Reference 1. An Introduction to Medicinal Chemistry FIFTH EDITION by Graham L. Patrick 2. Yuhong Xiang, Zhuoyong Zhang*, Aijing Xiao, and Jinxu Huo “Recent Studies of QSAR on Inhibitors of Estrogen Receptor and Human Eosinophil Phosphodiesterase” Department of Chemistry, Capital Normal University, Beijing 100048, P.R. China 3. Jitender Verma, Vijay M. Khedkar and Evans C. Coutinho “3D-QSAR in Drug Design - A Review” Department of Pharmaceutical Chemistry, Bombay College of Pharmacy, Kalina, Santacruz (E), Mumbai 400 098, India